17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      P19-29. Determining the optimal protocol for plasmid DNA vaccine delivery by intradermal in vivo electroporation

      abstract
      1 , , 1 , 2 , 3 , 3 , 1
      Retrovirology
      BioMed Central
      AIDS Vaccine 2009
      19–22 October 2009

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background In vivo electroporation (EP) has proven to significantly increase transfection efficiency and augment immune responses to plasmid DNA encoded vaccine antigens. In mice, we have attempted to establish the optimal EP immunization protocol for delivering HIV-1 antigens. Methods Mice were immunized with a plasmid encoding HIV-1 gag p37, either intradermally (id) with the DermaVax EP device, or intramuscularly (im) without EP. The different parameters explored were; the number of immunizations, the interval between immunizations, and the choice of priming (im or id). A novel Fluorospot assay was used to evaluate the vaccine specific cellular immune responses. This assay allows for detection of vaccine-specific cells that secrete IFN-γ, IL-2 and cells that simultaneously secrete both cytokines. In order to verify the Fluorospot results, conventional ELISpot assay was used. The humoral vaccine-specific response was evaluated by ELISA. Results The main findings were: 1) two and three id+EP immunizations induced similar and high cellular (up to 8000 IFN-γ SFC/million splenocytes) responses while antibody responses were increased after three as compared to two immunizations, 2) one month interval between immunizations was superior to two months in terms of cellular responses, and 3) repeated id+EP immunizations induced higher immune responses than im priming followed by id+EP boost. Conclusion The Fluorospot and the ELIspot assays gave similar results, confirming the sensitivity of the Fluorospot assay. Moreover, the Fluorospot assay enabled identification of high quality vaccine-specific cells simultaneously secreting both IFN-γ and IL-2. Three id+EP immunizations induced the highest levels of antibodies, while two immunizations were sufficient to induce a strong cellular response. In an upcoming longitudinal study we will further investigate the capacity of id EP to induce long lasting immune responses and also investigate the qualitative differences in responses induced by single vs. multiple immunizations.

          Related collections

          Author and article information

          Conference
          Retrovirology
          Retrovirology
          BioMed Central
          1742-4690
          2009
          22 October 2009
          : 6
          : Suppl 3
          : P349
          Affiliations
          [1 ]Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Solna, Sweden
          [2 ]CytoPulse Sciences Inc, MD, USA
          [3 ]Mabtech, Nacka Strand, Sweden
          Article
          1742-4690-6-S3-P349
          10.1186/1742-4690-6-S3-P349
          2767858
          35d2cf3c-f8af-499f-9e52-79c9ffaa7135
          Copyright © 2009 Hallengärd et al; licensee BioMed Central Ltd.
          AIDS Vaccine 2009
          Paris, France
          19–22 October 2009
          History
          Categories
          Poster Presentation

          Microbiology & Virology
          Microbiology & Virology

          Comments

          Comment on this article